Maaret Eskelinen, Tuomas Selander, Denise Peixoto Guimarães, Kai Kaarniranta, Kari Syrjänen, Matti Eskelinen
{"title":"人工智能模型可提高粪便免疫化学试验(FIT)在筛查结肠腺瘤中的诊断准确性。","authors":"Maaret Eskelinen, Tuomas Selander, Denise Peixoto Guimarães, Kai Kaarniranta, Kari Syrjänen, Matti Eskelinen","doi":"10.21873/anticanres.17414","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>This study evaluated the diagnostic accuracy (DA) for colorectal adenomas (CRA), screened by fecal immunochemical test (FIT), using five artificial intelligence (AI) models: logistic regression (LR), support vector machine (SVM), neural network (NN), random forest (RF), and gradient boosting machine (GBM). These models were tested together with clinical features categorized as low-risk (lowR) and high-risk (highR).</p><p><strong>Patients and methods: </strong>The colorectal neoplasia (CRN) screening cohort of 5,090 patients included 222 CRA patients and 264 non-CRA patients. Three consecutive fecal samples from each individual were analyzed by two fecal occult blood (FOB) assays. Five AI models including clinical features of CRN patients and CV test results were used to test the DA for CRA measured by receiving operating characteristic (ROC) curves.</p><p><strong>Results: </strong>In conventional ROC analysis, the area under the curve (AUC) values for different AI models ranged from 0.659 and 0.691 (for AIs with LR and SVM), while the highest AUC values were reached by NN, RF, and GBM models (0.809, 0.840, and 0.858, respectively). In the hierarchical summary ROC (HSROC) analysis, the AUC values were as follows: i) with lowR variables, AUC=0.508; ii) with highR variables, AUC=0.566 and iii) with all AI models, AUC= 0.789. The differences in AUC values were: between i) and ii) p=0.008; between i) and iii) p<0.0001 and between ii) and iii) p<0.0001.</p><p><strong>Conclusion: </strong>In detection of CRA, the AI models proved to be superior to the diagnostic features without AI. This is the first study to report that DA in the diagnosis of CRA can be enhanced by AI models that include clinical data of the patients and results of FIT test.</p>","PeriodicalId":8072,"journal":{"name":"Anticancer research","volume":"45 1","pages":"267-275"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting.\",\"authors\":\"Maaret Eskelinen, Tuomas Selander, Denise Peixoto Guimarães, Kai Kaarniranta, Kari Syrjänen, Matti Eskelinen\",\"doi\":\"10.21873/anticanres.17414\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>This study evaluated the diagnostic accuracy (DA) for colorectal adenomas (CRA), screened by fecal immunochemical test (FIT), using five artificial intelligence (AI) models: logistic regression (LR), support vector machine (SVM), neural network (NN), random forest (RF), and gradient boosting machine (GBM). These models were tested together with clinical features categorized as low-risk (lowR) and high-risk (highR).</p><p><strong>Patients and methods: </strong>The colorectal neoplasia (CRN) screening cohort of 5,090 patients included 222 CRA patients and 264 non-CRA patients. Three consecutive fecal samples from each individual were analyzed by two fecal occult blood (FOB) assays. Five AI models including clinical features of CRN patients and CV test results were used to test the DA for CRA measured by receiving operating characteristic (ROC) curves.</p><p><strong>Results: </strong>In conventional ROC analysis, the area under the curve (AUC) values for different AI models ranged from 0.659 and 0.691 (for AIs with LR and SVM), while the highest AUC values were reached by NN, RF, and GBM models (0.809, 0.840, and 0.858, respectively). In the hierarchical summary ROC (HSROC) analysis, the AUC values were as follows: i) with lowR variables, AUC=0.508; ii) with highR variables, AUC=0.566 and iii) with all AI models, AUC= 0.789. The differences in AUC values were: between i) and ii) p=0.008; between i) and iii) p<0.0001 and between ii) and iii) p<0.0001.</p><p><strong>Conclusion: </strong>In detection of CRA, the AI models proved to be superior to the diagnostic features without AI. This is the first study to report that DA in the diagnosis of CRA can be enhanced by AI models that include clinical data of the patients and results of FIT test.</p>\",\"PeriodicalId\":8072,\"journal\":{\"name\":\"Anticancer research\",\"volume\":\"45 1\",\"pages\":\"267-275\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anticancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/anticanres.17414\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anticancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/anticanres.17414","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting.
Background/aim: This study evaluated the diagnostic accuracy (DA) for colorectal adenomas (CRA), screened by fecal immunochemical test (FIT), using five artificial intelligence (AI) models: logistic regression (LR), support vector machine (SVM), neural network (NN), random forest (RF), and gradient boosting machine (GBM). These models were tested together with clinical features categorized as low-risk (lowR) and high-risk (highR).
Patients and methods: The colorectal neoplasia (CRN) screening cohort of 5,090 patients included 222 CRA patients and 264 non-CRA patients. Three consecutive fecal samples from each individual were analyzed by two fecal occult blood (FOB) assays. Five AI models including clinical features of CRN patients and CV test results were used to test the DA for CRA measured by receiving operating characteristic (ROC) curves.
Results: In conventional ROC analysis, the area under the curve (AUC) values for different AI models ranged from 0.659 and 0.691 (for AIs with LR and SVM), while the highest AUC values were reached by NN, RF, and GBM models (0.809, 0.840, and 0.858, respectively). In the hierarchical summary ROC (HSROC) analysis, the AUC values were as follows: i) with lowR variables, AUC=0.508; ii) with highR variables, AUC=0.566 and iii) with all AI models, AUC= 0.789. The differences in AUC values were: between i) and ii) p=0.008; between i) and iii) p<0.0001 and between ii) and iii) p<0.0001.
Conclusion: In detection of CRA, the AI models proved to be superior to the diagnostic features without AI. This is the first study to report that DA in the diagnosis of CRA can be enhanced by AI models that include clinical data of the patients and results of FIT test.
期刊介绍:
ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed.
ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies).
Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.